Prilocaine or Bupivacaine for Spinal Anesthesiain Pregnant
Césarcaïne
Comparison of the Duration of Motor Block After Spinal Anesthesia for Planned Cesarean Sections: Hyperbaric Prilocaïne Versus Hyperbaric Bupivacaine
1 other identifier
interventional
50
1 country
1
Brief Summary
The planned cesarean section is an intervention with a standard operating time of less than 40 minutes in trained teams. Hyperbaric Bupivacaine is the local anesthetic (LA) reference for these operations. But the duration of its motor block is generally greater than 3 hours. The purpose of this study is to show a reduction in motor block time with hyperbaric Prilocaine by at least 30 minutes, which would allow mothers and their children to return to the maternity ward earlier and thus improve the circulation of patients within the maternity's PACU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started May 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2017
CompletedFirst Posted
Study publicly available on registry
February 15, 2018
CompletedStudy Start
First participant enrolled
May 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 7, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2020
CompletedDecember 11, 2018
March 1, 2018
2 years
December 21, 2017
December 10, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
duration of motor block
To compare the duration of motor block after spinal anesthesia with hyperbaric Prilocaïne versus hyperbaric Bupivacaine This evaluation is done every 15 min from the entrance to the recovery room (PACU); the motor block stops being evaluated when the modified bromination score reaches 4
up to 6 hours
Secondary Outcomes (13)
The upper sensory level
15 minutes after the LA injection
Hypotensive episodes
1 day
The time between injection and incision
1 day
The duration of the intervention
1 day
The time to return to the standard maternity ward
1 day
- +8 more secondary outcomes
Study Arms (2)
Hyperbaric Bupivacaine
OTHERspinal anesthesia for planned cesarean sections control group
Hyperbaric Prilocaïne
ACTIVE COMPARATORspinal anesthesia for planned cesarean sections
Interventions
spinal anesthesia for planned cesarean sections
Eligibility Criteria
You may qualify if:
- Normal pregnancy
- Scheduled caesarean section
- Non-multiple pregnancy
- Age of patient: 18 years and over
- Height of patient: between 155 and 175 cm
- Affiliated patients or beneficiaries of a Social Security System
- Signature of the patient's consent
You may not qualify if:
- Patient \<18 years
- Pathological pregnancy
- Multiple pregnancy
- Emergency caesarean
- Patients who cannot give informed consent (not French speaking)
- Refusal of the patient
- Contraindications to spinal anesthesia
- Contraindications to Prilocaine
- Contraindications to Bupivacaine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Montpellierlead
- Hopital Saint Rochcollaborator
Study Sites (1)
Uhmontpellier
Montpellier, 34295, France
Related Publications (1)
Chapron K, Sleth JC, Capdevila X, Bringuier S, Dadure C. Hyperbaric prilocaine vs. hyperbaric bupivacaine for spinal anaesthesia in women undergoing elective caesarean section: a comparative randomised double-blind study. Anaesthesia. 2021 Jun;76(6):777-784. doi: 10.1111/anae.15342. Epub 2021 Jan 11.
PMID: 33428221DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
christophe DADURE
University Hospital, Montpellier
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 21, 2017
First Posted
February 15, 2018
Study Start
May 7, 2018
Primary Completion
May 7, 2020
Study Completion
August 30, 2020
Last Updated
December 11, 2018
Record last verified: 2018-03